Sarcoma [clinicaltrials_resource:de44dc73df720684ee1b130e7c8d0af4]
The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities [clinicaltrials:NCT00001188]The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors [clinicaltrials:NCT00001189]A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors [clinicaltrials:NCT00001209]A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [clinicaltrials:NCT00001300]A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy [clinicaltrials:NCT00001573]Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity [clinicaltrials:NCT00001577]Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus [clinicaltrials:NCT00002459]Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer [clinicaltrials:NCT00002466]Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer [clinicaltrials:NCT00002485]Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002492]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer [clinicaltrials:NCT00002515]Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma [clinicaltrials:NCT00002516]Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002526]Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma [clinicaltrials:NCT00002539]Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors [clinicaltrials:NCT00002543]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus [clinicaltrials:NCT00002546]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma [clinicaltrials:NCT00002601]Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [clinicaltrials:NCT00002608]Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002641]clinicaltrials:NCT00002643Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002738]Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma [clinicaltrials:NCT00002764]Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002791]clinicaltrials:NCT00002804Docetaxel in Treating Children With Recurrent Solid Tumors [clinicaltrials:NCT00002825]Cryosurgery in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002863]Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00002898]Altretamine and Etoposide in Treating Patients With HIV-Related Cancer [clinicaltrials:NCT00002936]Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma [clinicaltrials:NCT00002974]Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002985]Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus [clinicaltrials:NCT00002993]clinicaltrials:NCT00002995Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00003008]Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer [clinicaltrials:NCT00003022]Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer [clinicaltrials:NCT00003023]Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma [clinicaltrials:NCT00003052]Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus [clinicaltrials:NCT00003054]Troglitazone in Treating Patients With Liposarcoma [clinicaltrials:NCT00003058]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma [clinicaltrials:NCT00003081]Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus [clinicaltrials:NCT00003128]
condition [clinicaltrials_vocabulary:condition]
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000660]A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma [clinicaltrials:NCT00000681]Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000687]A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000694]Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma [clinicaltrials:NCT00000695]A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000725]A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000763]A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma [clinicaltrials:NCT00000769]Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy [clinicaltrials:NCT00000807]A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00000954]A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS [clinicaltrials:NCT00000987]A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00000996]Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS [clinicaltrials:NCT00001059]A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00001113]The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma [clinicaltrials:NCT00001114]The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities [clinicaltrials:NCT00001188]The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors [clinicaltrials:NCT00001189]A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors [clinicaltrials:NCT00001209]Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens [clinicaltrials:NCT00001294]A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [clinicaltrials:NCT00001300]New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma [clinicaltrials:NCT00001335]A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas [clinicaltrials:NCT00001564]clinicaltrials:NCT00001566Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity [clinicaltrials:NCT00001577]Stem Cell Transplantation for Metastatic Solid Tumors [clinicaltrials:NCT00001880]A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. [clinicaltrials:NCT00002093]Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002105]A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002131]Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. [clinicaltrials:NCT00002147]Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders [clinicaltrials:NCT00002153]Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. [clinicaltrials:NCT00002167]A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002188]Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals [clinicaltrials:NCT00002189]A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002212]Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002226]Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma [clinicaltrials:NCT00002259]A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma [clinicaltrials:NCT00002262]A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma [clinicaltrials:NCT00002314]A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002318]A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002319]
condition browse [clinicaltrials_vocabulary:condition-browse]
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000660]A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma [clinicaltrials:NCT00000681]Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000687]A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000694]Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma [clinicaltrials:NCT00000695]A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000725]A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma [clinicaltrials:NCT00000763]A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma [clinicaltrials:NCT00000769]Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy [clinicaltrials:NCT00000807]A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00000954]A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS [clinicaltrials:NCT00000987]A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00000996]Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS [clinicaltrials:NCT00001059]A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00001113]The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma [clinicaltrials:NCT00001114]The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities [clinicaltrials:NCT00001188]The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors [clinicaltrials:NCT00001189]A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors [clinicaltrials:NCT00001209]Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens [clinicaltrials:NCT00001294]A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [clinicaltrials:NCT00001300]New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma [clinicaltrials:NCT00001335]A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas [clinicaltrials:NCT00001564]clinicaltrials:NCT00001566Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity [clinicaltrials:NCT00001577]Stem Cell Transplantation for Metastatic Solid Tumors [clinicaltrials:NCT00001880]A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. [clinicaltrials:NCT00002093]Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002105]A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002131]Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. [clinicaltrials:NCT00002147]Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders [clinicaltrials:NCT00002153]Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. [clinicaltrials:NCT00002167]A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002188]Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals [clinicaltrials:NCT00002189]A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002212]Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002226]Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma [clinicaltrials:NCT00002259]A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma [clinicaltrials:NCT00002262]A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma [clinicaltrials:NCT00002314]A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002318]A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma [clinicaltrials:NCT00002319]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
eligibility for clinicaltrials:NCT02423863 [clinicaltrials_resource:1b0a08f245c1e5323d5aecf79f01b3a8]eligibility for clinicaltrials:NCT00620295 [clinicaltrials_resource:2e0021b03243a045dfc7ddcba0469fc7]eligibility for clinicaltrials:NCT00781209 [clinicaltrials_resource:76096edb6e139efa79d7f5b6297c99d8]eligibility for clinicaltrials:NCT00624962 [clinicaltrials_resource:c737456bfe2e986d5711f13965dd3e86]eligibility for clinicaltrials:NCT00622674 [clinicaltrials_resource:c978bea94903fcaeabc9aa26101dba51]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT02423863 [clinicaltrials_resource:1b0a08f245c1e5323d5aecf79f01b3a8]eligibility for clinicaltrials:NCT00620295 [clinicaltrials_resource:2e0021b03243a045dfc7ddcba0469fc7]eligibility for clinicaltrials:NCT00781209 [clinicaltrials_resource:76096edb6e139efa79d7f5b6297c99d8]eligibility for clinicaltrials:NCT00087191 [clinicaltrials_resource:c6153ab45d511dd1a4eec9048a3009b9]eligibility for clinicaltrials:NCT00624962 [clinicaltrials_resource:c737456bfe2e986d5711f13965dd3e86]eligibility for clinicaltrials:NCT00622674 [clinicaltrials_resource:c978bea94903fcaeabc9aa26101dba51]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Sarcoma [clinicaltrials_resource:de44dc73df720684ee1b130e7c8d0af4]
Bio2RDF identifier
de44dc73df720684ee1b130e7c8d0af4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:de44dc73df720684ee1b130e7c8d0af4
identifier
clinicaltrials_resource:de44dc73df720684ee1b130e7c8d0af4
title
Sarcoma
@en
type
label
Sarcoma [clinicaltrials_resource:de44dc73df720684ee1b130e7c8d0af4]
@en